Cohortias was formed because from a board member’s personal experience. After one of his close relatives was diagnosed with a then untreatable condition, he pursued alternative options in clinical research and discovered the lack of resources available in Latin America.
This motivated him to start a conversation between physicians and leaders in clinical research with an International CRO (Julius Clinical).
After a long period of planning and dialogue between the two, Cohortias was formed with one goal in mind: To provide the Latin American population with the opportunity to participate in potentially life saving treatments through clinical research.
Our main goal is providing a hassle-free alternative to our clients through our infrastructure in Latin America (LATAM), we offer an easier way to launch trials and clinical studies following high quality standards and applicable legislation.
Our service vocation is based on a unique team, capable of blending their academic training with a global business mindset to bring the highest level of quality and operational excellence, this has prompted us to adopt a quality management model and the implementation of a quality policy that is based on the following premises:
Why Latin America?
Several factors contribute to Latin America being a region of choice to conduct your clinical trials:
Over 600 million inhabitants and 80% urban population. Large metropolitan areas provide patient concentrations for stronger enrollment.
Compliance & Retention
Strong patient-doctor relationship built upon the health infrastructure of each country, this is why drop-out rates in the region are one-third to those of US and EU.
Lack Of Language Barrier
Only 2 languages – Spanish and Portuguese. With many english bilingual (English is predominant in the region).
Cardiovascular, arthritis, cancer, and infectious diseases are as prevalent as in the United States.